复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010  2009 
复星医药(600196) 利润表
单位:万元
报表日期2019-09-302019-06-302019-03-312018-12-312018-09-30
一、营业总收入2,122,761.871,417,276.86673,001.422,491,827.361,814,238.49
营业收入2,122,761.871,417,276.86673,001.422,491,827.361,814,238.49
二、营业总成本1,985,799.771,314,852.84627,275.442,367,627.571,698,847.50
营业成本853,665.75559,898.31275,100.111,036,530.87757,032.40
营业税金及附加17,043.8611,651.895,894.7725,584.0218,548.29
销售费用740,603.70499,844.85226,200.33848,753.27596,135.98
管理费用180,064.57111,899.2654,310.24223,943.73160,843.03
财务费用65,419.0046,620.2125,812.7572,419.2249,457.10
研发费用129,002.8984,938.3139,362.97147,961.23111,419.42
资产减值损失----122.229,719.033,119.96
公允价值变动收益-13,028.036,410.9917,072.0620,436.1734,130.23
投资收益153,747.51104,465.4332,806.45181,545.41115,657.16
其中:对联营企业和合营企业的投资收益111,850.3073,412.2030,161.27134,899.6398,303.31
汇兑收益----------
三、营业利润293,125.80221,751.4799,083.18353,553.38278,015.95
加:营业外收入6,083.71584.30291.318,286.01958.26
减:营业外支出3,344.542,720.78943.293,880.102,041.23
其中:非流动资产处置损失----------
四、利润总额295,864.97219,614.9898,431.19357,959.28276,932.98
减:所得税费用50,305.2737,652.0913,347.2755,971.0743,029.33
五、净利润245,559.70181,962.8985,083.92301,988.21233,903.65
归属于母公司所有者的净利润206,370.41151,611.9871,229.17270,792.34209,415.24
少数股东损益39,189.2830,350.9113,854.7631,195.8724,488.42
六、每股收益
基本每股收益(元/股)0.81000.59000.28001.07000.8300
稀释每股收益(元/股)0.81000.59000.28001.07000.8300
七、其他综合收益3,495.854,397.521,109.21-66,868.46-53,219.75
八、综合收益总额249,055.55186,360.4286,193.13235,119.76180,683.91
归属于母公司所有者的综合收益总额209,965.02154,492.3570,933.98209,938.74152,218.74
归属于少数股东的综合收益总额39,090.5331,868.0715,259.1525,181.0228,465.16
下载全部历史数据到excel中 返回页顶